All Updates

All Updates

icon
Filter
Product updates
Tempus launches AI-enabled clinical assistant, Tempus One
Precision Medicine
Jun 1, 2023
This week:
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Funding
OceanWell raises USD 11 million in Series A funding to build water farms
Conservation Tech
Yesterday
Product updates
H launches Runner H, an AI agent for business automation
Foundation Models
Yesterday
Partnerships
Capgemini partners with Mistral AI and Microsoft to expand GenAI solutions globally
Foundation Models
Yesterday
Funding
Product updates
Converge Bio launches biotech LLM platform with USD 5.5 million seed funding
Foundation Models
Yesterday
Partnerships
Snowflake partners with Anthropic to integrate Claude AI models into Cortex AI platform
Foundation Models
Yesterday
Product updates
DeepSeek releases AI reasoning model DeepSeek-R1
Foundation Models
Yesterday
Industry news
Partnerships
ICEYE partners with Lockheed Martin and Finnish firms to develop defense space technologies
Next-gen Satellites
Yesterday
Partnerships
Dematic installs AutoStore system at South West Healthcare logistics hub
Logistics Tech
Yesterday
Precision Medicine

Precision Medicine

Jun 1, 2023

Tempus launches AI-enabled clinical assistant, Tempus One

Product updates

  • AI-driven bioinformatics company Tempus has launched Tempus One, an AI-enabled clinical assistant that provides clinicians with patient insights. Tempus One can be accessed through the Tempus Hub desktop and mobile app.

  • Tempus One is a voice and text assistant that allows clinicians to access patient clinical and molecular profiles and other datasets. Key features include accessing new clinical test reports, filtering patient incidence, reviewing actionable biomarkers, and querying clinical guidelines for standard-of-care insights. The technology leverages Tempus' extensive healthcare dataset and uses generative AI to improve clinical care and patient outcomes.

  • The company claims that Tempus One simplifies the process of genomic testing, augments precision-oncology efforts, and enables clinicians to make data-driven treatment decisions. Tempus has refined the technology based on physician feedback and user testing, incorporating generative AI into clinical care settings and is set to be accessible via the Tempus Hub platform later this year.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.